Oncology

Please note that you will be redirected to one of our sister websites, ManagingMyeloma.com or PracticalOncologist.com, where these complimentary courses are maintained. You will need to log in if you are already a member of the websites or take a minute to register for complimentary membership.

Reducing the Risk of Oncologic Emergencies: Assessment and Treatment of Severe Neutropenia
Reducing the Risk of Oncologic Emergencies: Assessment and Treatment of Severe Neutropenia
Rajni Sinha, MD, MRCP; R. Donald Harvey III, PharmD, FCCP, BCOP
Release Date: June 14, 2013
Expiration Date: June 14, 2014
A two-part module of streaming video discussions between leading oncology experts that will assist physicians and their health care team members identify patients that are at high risk of treatment-associated severe neutropenia, as well as interventions specifically designed for reducing the duration. This discussion will include newly available agents and prophylactic strategies with the goal of reducing the risk of febrile neutropenia (FN) occurrence and its associated consequences of infection and increased risk of death.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Teva Pharmaceuticals.
Begin
 
Novel Approaches for the Management of Elderly and Infirm Multiple Myeloma Patients
Novel Approaches for the Management of Elderly and Infirm Multiple Myeloma Patients
Antonio Palumbo, MD and Sandra E. Kurtin, RN, MS, AOCN®, ANP-C
Release Date: March 29, 2013
Expiration Date: March 29, 2014
World-leading myeloma expert, Dr. Antonio Palumbo, describes strategies to tailoring therapy for specific elderly multiple myeloma patient needs, including recently proposed algorithms to assist in adjusting regimens as needed. Sandra Kurtin, nurse practitioner and assistant professor of clinical medicine and nursing at the University of Arizona further discusses special practice considerations including age, performance status, previous medical history, and tailoring supportive care based on patient specific risk factors for treatment associated side effects.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Millennium: The Takeda Oncology Company and Celgene Corporation.
Begin
 
Advances in Consolidation, Stem Cell Collection, and Transplantation
Advances in Consolidation, Stem Cell Collection, and Transplantation
Sergio Giralt, MD, and Beth Faiman, PhDc, RN, MSN, APRN-BC, AOCN®
Release Date: March 15, 2013
Expiration Date: March 15, 2014
Sergio Giralt, MD, and Beth Faiman, PhDc, RN, MSN, APRN-BC, AOCN®, navigate the management decision process for transplant-eligible patients, including tailoring treatment planning, establishing treatment goals, primary therapy choices, and addressing patient concerns as to whether autologous stem cell transplant is a necessity.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Millennium: The Takeda Oncology Company and Celgene Corporation.
Begin